119 related articles for article (PubMed ID: 30659997)
1. New anthra[2,3-b]furancarboxamides: A role of positioning of the carboxamide moiety in antitumor properties.
Volodina YL; Dezhenkova LG; Tikhomirov AS; Tatarskiy VV; Kaluzhny DN; Moisenovich AM; Moisenovich MM; Isagulieva AK; Shtil AA; Tsvetkov VB; Shchekotikhin AE
Eur J Med Chem; 2019 Mar; 165():31-45. PubMed ID: 30659997
[TBL] [Abstract][Full Text] [Related]
2. New antitumor anthra[2,3-b]furan-3-carboxamides: Synthesis and structure-activity relationship.
Tikhomirov AS; Lin CY; Volodina YL; Dezhenkova LG; Tatarskiy VV; Schols D; Shtil AA; Kaur P; Chueh PJ; Shchekotikhin AE
Eur J Med Chem; 2018 Mar; 148():128-139. PubMed ID: 29459273
[TBL] [Abstract][Full Text] [Related]
3. Amides of pyrrole- and thiophene-fused anthraquinone derivatives: A role of the heterocyclic core in antitumor properties.
Tikhomirov AS; Litvinova VA; Andreeva DV; Tsvetkov VB; Dezhenkova LG; Volodina YL; Kaluzhny DN; Treshalin ID; Schols D; Ramonova AA; Moisenovich MM; Shtil AA; Shchekotikhin AE
Eur J Med Chem; 2020 Aug; 199():112294. PubMed ID: 32428792
[TBL] [Abstract][Full Text] [Related]
4. Discovery of antitumor anthra[2,3-b]furan-3-carboxamides: Optimization of synthesis and evaluation of antitumor properties.
Shchekotikhin AE; Dezhenkova LG; Tsvetkov VB; Luzikov YN; Volodina YL; Tatarskiy VV; Kalinina AA; Treshalin MI; Treshalina HM; Romanenko VI; Kaluzhny DN; Kubbutat M; Schols D; Pommier Y; Shtil AA; Preobrazhenskaya MN
Eur J Med Chem; 2016 Apr; 112():114-129. PubMed ID: 26890118
[TBL] [Abstract][Full Text] [Related]
5. Thiophene-2-carboxamide derivatives of anthraquinone: A new potent antitumor chemotype.
Volodina YL; Tikhomirov AS; Dezhenkova LG; Ramonova AA; Kononova AV; Andreeva DV; Kaluzhny DN; Schols D; Moisenovich MM; Shchekotikhin AE; Shtil AA
Eur J Med Chem; 2021 Oct; 221():113521. PubMed ID: 34082225
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and evaluation of 4-substituted anthra[2,1-c][1,2,5]thiadiazole-6,11-dione derivatives as novel non-camptothecin topoisomerase I inhibitors.
Dong G; Fang Y; Liu Y; Liu N; Wu S; Zhang W; Sheng C
Bioorg Med Chem Lett; 2017 May; 27(9):1929-1933. PubMed ID: 28351590
[TBL] [Abstract][Full Text] [Related]
7. The first series of 4,11-bis[(2-aminoethyl)amino]anthra[2,3-b]furan-5,10-diones: Synthesis and anti-proliferative characteristics.
Shchekotikhin AE; Glazunova VA; Dezhenkova LG; Shevtsova EK; Traven' VF; Balzarini J; Huang HS; Shtil AA; Preobrazhenskaya MN
Eur J Med Chem; 2011 Jan; 46(1):423-8. PubMed ID: 21144624
[TBL] [Abstract][Full Text] [Related]
8. Novel multi-targeting anthra[2,3-b]thiophene-5,10-diones with guanidine-containing side chains: interaction with telomeric G-quadruplex, inhibition of telomerase and topoisomerase I and cytotoxic properties.
Ilyinsky NS; Shchyolkina AK; Borisova OF; Mamaeva OK; Zvereva MI; Azhibek DM; Livshits MA; Mitkevich VA; Balzarini J; Sinkevich YB; Luzikov YN; Dezhenkova LG; Kolotova ES; Shtil AA; Shchekotikhin AE; Kaluzhny DN
Eur J Med Chem; 2014 Oct; 85():605-14. PubMed ID: 25127152
[TBL] [Abstract][Full Text] [Related]
9. Heterocyclic ring expansion yields anthraquinone derivatives potent against multidrug resistant tumor cells.
Tikhomirov AS; Tsvetkov VB; Volodina YL; Litvinova VA; Andreeva DV; Dezhenkova LG; Kaluzhny DN; Treshalin ID; Shtil AA; Shchekotikhin AE
Bioorg Chem; 2022 Oct; 127():105925. PubMed ID: 35728293
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and cytotoxic properties of 4,11-bis[(aminoethyl)amino]anthra[2,3-b]thiophene-5,10-diones, novel analogues of antitumor anthracene-9,10-diones.
Shchekotikhin AE; Glazunova VA; Dezhenkova LG; Luzikov YN; Sinkevich YB; Kovalenko LV; Buyanov VN; Balzarini J; Huang FC; Lin JJ; Huang HS; Shtil AA; Preobrazhenskaya MN
Bioorg Med Chem; 2009 Mar; 17(5):1861-9. PubMed ID: 19208482
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitumor activity of cyclopentane-fused anthraquinone derivatives.
Tikhomirov AS; Sinkevich YB; Dezhenkova LG; Kaluzhny DN; Ilyinsky NS; Borshchevskiy VI; Schols D; Shchekotikhin AE
Eur J Med Chem; 2024 Feb; 265():116103. PubMed ID: 38176358
[TBL] [Abstract][Full Text] [Related]
12. Tri-armed ligands of G-quadruplex on heteroarene-fused anthraquinone scaffolds: Design, synthesis and pre-screening of biological properties.
Tikhomirov AS; Tsvetkov VB; Kaluzhny DN; Volodina YL; Zatonsky GV; Schols D; Shchekotikhin AE
Eur J Med Chem; 2018 Nov; 159():59-73. PubMed ID: 30268824
[TBL] [Abstract][Full Text] [Related]
13. Ring fusion strategy for the synthesis of anthra[2,3-d]oxazole-2-thione-5,10-dione homologues as DNA topoisomerase inhibitors and as antitumor agents.
Chen CL; Liu FL; Lee CC; Chen TC; Chang WW; Guh JH; Ahmed Ali AA; Chang DM; Huang HS
Eur J Med Chem; 2014 Nov; 87():30-8. PubMed ID: 25240093
[TBL] [Abstract][Full Text] [Related]
14. Natural product-based design, synthesis and biological evaluation of anthra[2,1-d]thiazole-6,11-dione derivatives from rhein as novel antitumour agents.
Liang YK; Yue ZZ; Li JX; Tan C; Miao ZH; Tan WF; Yang CH
Eur J Med Chem; 2014 Sep; 84():505-15. PubMed ID: 25050882
[TBL] [Abstract][Full Text] [Related]
15. Ring fusion strategy for synthesis and lead optimization of sulfur-substituted anthra[1,2-c][1,2,5]thiadiazole-6,11-dione derivatives as promising scaffold of antitumor agents.
Lee YR; Chen TC; Lee CC; Chen CL; Ahmed Ali AA; Tikhomirov A; Guh JH; Yu DS; Huang HS
Eur J Med Chem; 2015 Sep; 102():661-76. PubMed ID: 26344783
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, cytotoxicity and human telomerase inhibition activities of a series of 1,2-heteroannelated anthraquinones and anthra[1,2-d]imidazole-6,11-dione homologues.
Huang HS; Chen TC; Chen RH; Huang KF; Huang FC; Jhan JR; Chen CL; Lee CC; Lo Y; Lin JJ
Bioorg Med Chem; 2009 Nov; 17(21):7418-28. PubMed ID: 19804981
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological activities of topopyrones.
Zaleski PA; Maini R; Leiris SJ; Elban MA; Hecht SM
J Nat Prod; 2012 Apr; 75(4):577-85. PubMed ID: 22462811
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and cytotoxic activity of a new series of topoisomerase I inhibitors.
Dallavalle S; Gattinoni S; Mazzini S; Scaglioni L; Merlini L; Tinelli S; Beretta GL; Zunino F
Bioorg Med Chem Lett; 2008 Feb; 18(4):1484-9. PubMed ID: 18248813
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antiproliferative activity of 1,4-bis(dimethylamino)-9,10-anthraquinone derivatives against P388 mouse leukemic tumor cells.
Jin GZ; Jin HS; Jin LL
Arch Pharm Res; 2011 Jul; 34(7):1071-6. PubMed ID: 21811913
[TBL] [Abstract][Full Text] [Related]
20. Overcoming doxorubicin-resistance in the NCI/ADR-RES model cancer cell line by novel anthracene-9,10-dione derivatives.
Sangthong S; Ha H; Teerawattananon T; Ngamrojanavanich N; Neamati N; Muangsin N
Bioorg Med Chem Lett; 2013 Nov; 23(22):6156-60. PubMed ID: 24095089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
